Psychological and Behavioral Predictors of Vaccine Efficacy: Considerations for COVID-19
- PMID: 33501900
- PMCID: PMC7841255
- DOI: 10.1177/1745691621989243
Psychological and Behavioral Predictors of Vaccine Efficacy: Considerations for COVID-19
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine candidates are being evaluated, with the goal of conferring immunity on the highest percentage of people who receive the vaccine as possible. It is noteworthy that vaccine efficacy depends not only on the vaccine but also on characteristics of the vaccinated. Over the past 30 years, a series of studies has documented the impact of psychological factors on the immune system's vaccine response. Robust evidence has demonstrated that stress, depression, loneliness, and poor health behaviors can impair the immune system's response to vaccines, and this effect may be greatest in vulnerable groups such as the elderly. Psychological factors are also implicated in the prevalence and severity of vaccine-related side effects. These findings have generalized across many vaccine types and therefore may be relevant to the SARS-CoV-2 vaccine. In this review, we discuss these psychological and behavioral risk factors for poor vaccine responses, their relevance to the COVID-19 pandemic, as well as targeted psychological and behavioral interventions to boost vaccine efficacy and reduce side effects. Recent data suggest these psychological and behavioral risk factors are highly prevalent during the COVID-19 pandemic, but intervention research suggests that psychological and behavioral interventions can increase vaccine efficacy.
Keywords: COVID-19; SARS-CoV-2; depression; health behaviors; stress; vaccine efficacy.
Conflict of interest statement
Similar articles
-
SARS-CoV-2 Variants, Vaccines, and Host Immunity.Front Immunol. 2022 Jan 3;12:809244. doi: 10.3389/fimmu.2021.809244. eCollection 2021. Front Immunol. 2022. PMID: 35046961 Free PMC article. Review.
-
Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.J Virol. 2021 Nov 9;95(23):e0097421. doi: 10.1128/JVI.00974-21. Epub 2021 Sep 15. J Virol. 2021. PMID: 34523968 Free PMC article.
-
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629336 Review.
-
Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects.Rev Med Virol. 2021 May;31(3):e2183. doi: 10.1002/rmv.2183. Epub 2020 Oct 15. Rev Med Virol. 2021. PMID: 33594794 Free PMC article. Review.
-
Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.Front Immunol. 2021 Jun 30;12:658519. doi: 10.3389/fimmu.2021.658519. eCollection 2021. Front Immunol. 2021. PMID: 34276652 Free PMC article. Review.
Cited by
-
Effect of anxiety and depression on self-reported adverse reactions to COVID-19 vaccine: a cross-sectional study in Shanghai, China.BMC Public Health. 2023 Mar 3;23(1):425. doi: 10.1186/s12889-023-15118-8. BMC Public Health. 2023. PMID: 36869301 Free PMC article.
-
Breast cancer survivors' typhoid vaccine responses: Chemotherapy, obesity, and fitness make a difference.Brain Behav Immun. 2022 Jul;103:1-9. doi: 10.1016/j.bbi.2022.03.019. Epub 2022 Apr 1. Brain Behav Immun. 2022. PMID: 35378230 Free PMC article. Clinical Trial.
-
Two-Year-Span Breast Cancer Screening Uptake in Japan after the COVID-19 Pandemic and Its Association with the COVID-19 Vaccination.Cancers (Basel). 2024 May 5;16(9):1783. doi: 10.3390/cancers16091783. Cancers (Basel). 2024. PMID: 38730735 Free PMC article.
-
Increasing Efficacy of Covid-19 Vaccines by Lifestyle Interventions.Arch Razi Inst. 2022 Oct 31;77(5):1527-1538. doi: 10.22092/ARI.2021.356491.1854. eCollection 2022 Oct. Arch Razi Inst. 2022. PMID: 37123146 Free PMC article. Review.
-
Vaccination with SARS-CoV-2 inactivated vaccines reduced the risk of anxiety and depression in a population majored by health care workers during the recent omicron variant outbreak.Front Psychol. 2022 Nov 18;13:989952. doi: 10.3389/fpsyg.2022.989952. eCollection 2022. Front Psychol. 2022. PMID: 36467156 Free PMC article.
References
-
- Afsar B., Elsurer R., Eyileten T., Yilmaz M. I., Caglar K. (2009). Antibody response following hepatitis B vaccination in dialysis patients: Does depression and life quality matter? Vaccine, 27(42), 5865–5869. - PubMed
-
- Altena E., Baglioni C., Espie C. A., Ellis J., Gavriloff D., Holzinger B., Schlarb A., Frase L., Jernelov S., Riemann D. (2020). Dealing with sleep problems during home confinement due to the COVID-19 outbreak: Practical recommendations from a task force of the European CBT-I Academy. Journal of Sleep Research, 29, Article e13052. 10.1111/jsr.13052 - DOI - PubMed
-
- Barnett J. B., Dao M. C., Hamer D. H., Kandel R., Brandeis G., Wu D., Dallal G. E., Jacques P. F., Schreiber R., Kong E., Meydani S. N. (2016). Effect of zinc supplementation on serum zinc concentration and T cell proliferation in nursing home elderly: A randomized, double-blind, placebo-controlled trial. The American Journal of Clinical Nutrition, 103(3), 942–951. - PubMed
-
- Bohn-Goldbaum E., Pascoe A., Singh M. F., Singh N., Kok J., Dwyer D. E., Mathieson E., Booy R., Edwards K. M. (2020). Acute exercise decreases vaccine reactions following influenza vaccination among older adults. Brain, Behavior, & Immunity-Health, 1, Article 100009. 10.1016/j.bbih.2019.100009 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous